Related Experiment Video
Updated: Jun 18, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
A Case of Primary Biliary Cholangitis in a Patient With Multiple Sclerosis
Tigran Kakhktsyan1, Mesrop Aleksanyan1, Talar Acob1
1Internal Medicine, Capital Health Regional Medical Center, Trenton, USA.
This case study details a rare instance of primary biliary cholangitis (PBC) in an 81-year-old woman with a history of multiple sclerosis (MS). The findings underscore the importance of investigating autoimmune comorbidities in MS patients.
Area of Science:
- Neurology
- Hepatology
- Immunology
Background:
- Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease impacting the central nervous system.
- Patients with MS have an increased risk of other autoimmune conditions.
- Primary biliary cholangitis (PBC) is a rare autoimmune liver disease characterized by bile duct destruction.
Observation:
- An 81-year-old female patient with a history of MS and hypertension presented with a sacral ulcer and bacteremia.
- During hospitalization, she developed pruritus and elevated liver enzymes.
- Diagnostic workup revealed a gallstone, hepatomegaly, and confirmed PBC with elevated M2 antimitochondrial antibodies.
Findings:
- The patient was diagnosed with a rare co-occurrence of multiple sclerosis and primary biliary cholangitis.
- Treatment with ursodeoxycholic acid resulted in symptomatic improvement of PBC.
Implications:
- This case emphasizes the need for comprehensive autoimmune comorbidity screening in patients diagnosed with MS.
- It suggests a potential shared genetic or environmental etiology between MS and PBC.
- Further research is warranted to elucidate the association between these two autoimmune diseases and optimize management strategies.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Clinical Manifestations and Management
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

